Physician profile
Preethi Kumar
NPI 1588663942
$441.60
in general payments reported to CMS, 2019-2025
11 companies · $19.19 in 2025
The $19.19 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $23.75 · 2021: $89.93 · 2022: $87.73 · 2023: $41.85 · 2024: $34.27 · 2025: $19.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $95.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $95.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $88.51 | 2019-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Pfizer INC. | $79.80 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $67.34 | 2019-2022 | |
| Shire North American Group INC | $48.44 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.16 | 2021 | |
| Corium, LLC | $23.56 | 2023 | Azstarys |
| Sobi, INC | $19.76 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $19.19 | 2025 | Neffy |
| Tris Pharma INC | $18.47 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.38 | 2019 | |
| Sanofi Pasteur INC. | $13.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preethi Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.